Chapter 15 Mucosal Delivery of Liposome–Chitosan Nanoparticle Complexes
- 1 January 2009
- book chapter
- Published by Elsevier BV in Methods in Enzymology
- Vol. 465, 289-312
- https://doi.org/10.1016/s0076-6879(09)65015-1
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Chitosan nanoparticles for drug delivery to the eyeExpert Opinion on Drug Delivery, 2009
- Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteinsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Liposomal Nanomedicines: An Emerging FieldToxicologic Pathology, 2008
- Advances and challenges of nanotechnology-based drug delivery systemsExpert Opinion on Drug Delivery, 2007
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- Pharmacokinetics and Efficacies of Liposomal and Conventional Formulations of Tobramycin after Intratracheal Administration in Rats with Pulmonary Burkholderia cepacia InfectionAntimicrobial Agents and Chemotherapy, 2002
- Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin AInternational Journal of Pharmaceutics, 2001
- Aerosolization of Low Phase Transition Temperature Liposomal Tobramycin as a Dry Powder in an Animal Model of Chronic Pulmonary Infection Caused byPseudomonas aeruginosaJournal of Drug Targeting, 1999
- Liposome circulation time and tumor targeting: implications for cancer chemotherapyAdvanced Drug Delivery Reviews, 1995
- Diffusion of univalent ions across the lamellae of swollen phospholipidsJournal of Molecular Biology, 1965